title: Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17.
abstract: The specific mutation on the tau gene responsible for a neurodegenerative disease known as pallido-ponto-nigral degeneration (PPND) was recently located. PPND family members are at risk for an autosomal dominant form of frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). This study investigated whether individuals in this family would consider presymptomatic genetic testing. Surveys were sent to 66 at-risk individuals in the family; replies were received from 20 (30%). Family members were asked if they would consider having testing now or in the future, and to indicate their reasons for and against proceeding with testing. Fifty per cent (n=10) of those who were at risk and who responded indicated they would consider testing now, and 55% (n=11) would think about it in the future. The most frequently cited reasons to proceed with testing were to 'collaborate with research' (70%) and to 'know if my children are at risk' (45%). The most frequently cited reason not to pursue testing was 'I can enjoy my life more fully by not knowing' (50%). Results suggest that interest in determining whether they will manifest PPND is generally low among at-risk members of this family, despite wide support and participation in other research studies.
authors: University of Denver, Denver, Colorado, USA.
authors: C A
authors: CA
authors: McRae
authors: G
authors: G
authors: Diem
authors: T G
authors: TG
authors: Yamazaki
authors: A
authors: A
authors: Mitek
authors: Z K
authors: ZK
authors: Wszolek
mesh_terms: D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D003704:Dementia / Q000235:genetics*; D008040:Genetic Linkage; D005820:Genetic Testing; D005917:Globus Pallidus; D006801:Humans; D019636:Neurodegenerative Diseases / Q000235:genetics*; D020734:Parkinsonian Disorders / Q000235:genetics*; D011149:Pons; D013378:Substantia Nigra